Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20244) 20244
Book Chapter (260) 260
Magazine Article (43) 43
Dissertation (14) 14
Conference Proceeding (12) 12
Publication (9) 9
Web Resource (4) 4
Journal / eJournal (2) 2
Newspaper Article (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18094) 18094
male (12025) 12025
science & technology (10418) 10418
life sciences & biomedicine (10328) 10328
female (9991) 9991
aged (9423) 9423
middle aged (9095) 9095
carcinoma, transitional cell - pathology (8436) 8436
urinary bladder neoplasms - pathology (7189) 7189
biological and medical sciences (5915) 5915
medical sciences (5844) 5844
adult (5063) 5063
urology & nephrology (4962) 4962
carcinoma, transitional cell - surgery (4620) 4620
aged, 80 and over (3826) 3826
nephrology. urinary tract diseases (3818) 3818
tumors of the urinary system (3376) 3376
bladder cancer (3374) 3374
urinary bladder neoplasms - surgery (3351) 3351
oncology (3301) 3301
abridged index medicus (3238) 3238
urinary tract. prostate gland (3227) 3227
prognosis (3089) 3089
carcinoma, transitional cell - drug therapy (2905) 2905
neoplasm staging (2655) 2655
transitional cell carcinoma (2590) 2590
urinary bladder neoplasms - drug therapy (2436) 2436
carcinoma, transitional cell - diagnosis (2381) 2381
cancer (2317) 2317
carcinoma, transitional cell - mortality (2161) 2161
retrospective studies (2066) 2066
carcinoma, transitional cell - therapy (2061) 2061
carcinoma, transitional cell - genetics (1927) 1927
follow-up studies (1810) 1810
tumors (1763) 1763
urinary bladder neoplasms - genetics (1758) 1758
urinary bladder neoplasms - mortality (1739) 1739
urinary bladder neoplasms - therapy (1705) 1705
treatment outcome (1582) 1582
carcinoma, transitional cell - metabolism (1580) 1580
neoplasm invasiveness (1575) 1575
animals (1569) 1569
carcinoma (1568) 1568
urinary bladder neoplasms - diagnosis (1568) 1568
cystectomy (1516) 1516
immunohistochemistry (1431) 1431
urology (1407) 1407
carcinoma, transitional cell - secondary (1389) 1389
pathology (1357) 1357
urinary bladder neoplasms - metabolism (1347) 1347
chemotherapy (1226) 1226
combined modality therapy (1223) 1223
survival rate (1184) 1184
bladder (1180) 1180
antineoplastic combined chemotherapy protocols - therapeutic use (1156) 1156
kidney neoplasms - pathology (1136) 1136
urinary bladder - pathology (1035) 1035
administration, intravesical (1019) 1019
time factors (986) 986
care and treatment (964) 964
risk factors (950) 950
carcinoma, transitional cell (945) 945
urothelial carcinoma (940) 940
carcinoma, transitional cell - complications (937) 937
kidney neoplasms - surgery (927) 927
analysis (878) 878
pharmacology. drug treatments (877) 877
antineoplastic agents (835) 835
surgery (835) 835
neoplasm recurrence, local (827) 827
ureteral neoplasms - pathology (827) 827
carcinoma, transitional cell - immunology (812) 812
carcinoma, transitional cell - diagnostic imaging (809) 809
ureteral neoplasms - surgery (808) 808
carcinoma, transitional cell - radiotherapy (788) 788
disease-free survival (783) 783
survival analysis (782) 782
cisplatin - administration & dosage (778) 778
diagnosis, differential (778) 778
urinary bladder (761) 761
carcinoma, squamous cell - pathology (747) 747
carcinoma, transitional cell - epidemiology (743) 743
cystectomy - methods (742) 742
disease progression (726) 726
urinary bladder neoplasms - immunology (724) 724
medicine & public health (719) 719
prospective studies (708) 708
lymphatic metastasis (688) 688
adenocarcinoma (681) 681
mice (680) 680
bladder neoplasms (674) 674
research (659) 659
metastasis (642) 642
neoplasm metastasis (642) 642
urinary bladder neoplasms - radiotherapy (641) 641
sensitivity and specificity (635) 635
urinary system involvement in other diseases. miscellaneous (629) 629
carcinoma, transitional cell - urine (625) 625
kidney pelvis (625) 625
bcg vaccine - therapeutic use (617) 617
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18195) 18195
Japanese (1166) 1166
Spanish (600) 600
German (560) 560
French (373) 373
Chinese (289) 289
Italian (197) 197
Russian (169) 169
Portuguese (80) 80
Bulgarian (27) 27
Polish (26) 26
Korean (24) 24
Hebrew (22) 22
Turkish (16) 16
Hungarian (14) 14
Czech (13) 13
Romanian (10) 10
Croatian (9) 9
Danish (8) 8
Dutch (8) 8
Serbian (7) 7
Finnish (3) 3
Norwegian (3) 3
Persian (3) 3
Afrikaans (2) 2
Lithuanian (2) 2
Arabic (1) 1
Bosnian (1) 1
Icelandic (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases
by van Bussel, Mark T.J and Pluim, Dick and Milojkovic Kerklaan, Bojana and Bol, Mijke and Sikorska, Karolina and Linders, Dorothé T.C and van den Broek, Daan and Beijnen, Jos H and Schellens, Jan H.M and Brandsma, Dieta
Neurology, ISSN 0028-3878, 02/2020, Volume 94, Issue 5, pp. e521 - e528
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Small Cell Lung Carcinoma - cerebrospinal fluid | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | ErbB Receptors - genetics | Ovarian Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - cerebrospinal fluid | Lung Neoplasms - pathology | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Meningeal Carcinomatosis - secondary | Carcinoma - cerebrospinal fluid | Meningeal Carcinomatosis - genetics | Epithelial Cell Adhesion Molecule | Small Cell Lung Carcinoma - secondary | Gastrointestinal Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - secondary | Flow Cytometry | Sensitivity and Specificity | Carcinoma, Lobular - cerebrospinal fluid | Aged, 80 and over | Meningeal Carcinomatosis - cerebrospinal fluid | Adult | Female | Carcinoma, Ductal, Breast - cerebrospinal fluid | Carcinoma, Transitional Cell - cerebrospinal fluid | Carcinoma, Ductal, Breast - secondary | Carcinoma - secondary | Carcinoma, Lobular - secondary | Lung Neoplasms - genetics | Meningeal Carcinomatosis - diagnosis | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Transitional Cell - diagnosis | Carcinoma - diagnosis | Carcinoma, Lobular - diagnosis | Carcinoma, Ductal, Breast - diagnosis | Magnetic Resonance Imaging | Breast Neoplasms - pathology | Neoplastic Cells, Circulating | Small Cell Lung Carcinoma - diagnosis | Aged | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Bladder cancers arise from distinct urothelial sub-populations
by Van Batavia, Jason and Yamany, Tammer and Molotkov, Andrei and Dan, Hanbin and Mansukhani, Mahesh and Batourina, Ekaterina and Schneider, Kerry and Oyon, Daniel and Dunlop, Mark and Wu, Xue-Ru and Cordon-Cardo, Carlos and Mendelsohn, Cathy
Nature cell biology, ISSN 1465-7392, 01/2014, Volume 16, Issue 10, pp. 982 - 991
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Carcinoma, Papillary - genetics | Butylhydroxybutylnitrosamine | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Carcinoma, Squamous Cell - chemically induced | Male | Mice, 129 Strain | Urinary Bladder Neoplasms - chemically induced | Carcinoma, Papillary - metabolism | Carcinoma in Situ - genetics | Urinary Bladder Neoplasms - genetics | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Female | Carcinoma, Transitional Cell - chemically induced | Urinary Bladder Neoplasms - metabolism | Carcinoma, Transitional Cell - genetics | Mice, Transgenic | Carcinoma, Transitional Cell - metabolism | Keratin-5 - genetics | Carcinoma, Papillary - chemically induced | Mice, Knockout | Cell Lineage | Microscopy, Confocal | Animals | Keratin-5 - metabolism | Luminescent Proteins - genetics | Carcinoma in Situ - metabolism | Carcinoma in Situ - chemically induced | Luminescent Proteins - metabolism | Development and progression | Genetic aspects | Bladder cancer | Identification and classification | Cancer cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases
by Davick, Jonathan J and Frierson, Henry F and Smolkin, Mark and Gru, Alejandro A
Human pathology, ISSN 0046-8177, 11/2018, Volume 81, pp. 184 - 191
Immunohistochemistry | PD-L1 | Immune checkpoint inhibitors | Transitional cell carcinoma | Urothelial carcinoma | Bladder cancer | PD-1 | Life Sciences & Biomedicine | Pathology | Science & Technology | Carcinoma, Transitional Cell - mortality | Carcinoma, Small Cell - surgery | Adenocarcinoma - pathology | Tissue Array Analysis | Carcinoma, Squamous Cell - pathology | Humans | Carcinoma, Squamous Cell - surgery | Urothelium - pathology | Carcinoma, Squamous Cell - mortality | Neoplasm Grading | Urinary Bladder Neoplasms - pathology | Urinary Bladder Neoplasms - mortality | Biomarkers, Tumor - analysis | Adenocarcinoma - immunology | Risk Factors | Carcinoma, Squamous Cell - immunology | Urinary Bladder Neoplasms - surgery | Carcinoma, Small Cell - immunology | Cystectomy | Carcinoma, Transitional Cell - pathology | Carcinoma, Transitional Cell - immunology | Urothelium - immunology | Urinary Bladder Neoplasms - immunology | B7-H1 Antigen - analysis | Carcinoma, Transitional Cell - surgery | Urothelium - surgery | Carcinoma, Small Cell - pathology | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Monoclonal antibodies | Squamous cell carcinoma | Analysis | Tumors | Studies | Immunoglobulins | Hypotheses | Medical prognosis | Immunotherapy | Clinical trials | Biomarkers | Metastasis | Cancer therapies | Immune system | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Inter‐ and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma
by Downes, Michelle R and Slodkowska, Elzbieta and Katabi, Nora and Jungbluth, Achim A and Xu, Bin
Histopathology, ISSN 0309-0167, 01/2020, Volume 76, Issue 2, pp. 191 - 200
PD‐L1 immunohistochemistry assay | head and neck carcinoma | urothelial carcinoma | assay comparison | breast carcinoma | Pathology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Immunohistochemistry | Squamous Cell Carcinoma of Head and Neck - metabolism | Tissue Array Analysis | Urinary Bladder Neoplasms - diagnosis | Humans | Squamous Cell Carcinoma of Head and Neck - pathology | Head and Neck Neoplasms - metabolism | Urothelium - pathology | Breast Neoplasms - metabolism | Urinary Bladder Neoplasms - pathology | Female | Retrospective Studies | Urinary Bladder Neoplasms - metabolism | Antibodies, Monoclonal - immunology | Carcinoma, Transitional Cell - diagnosis | Squamous Cell Carcinoma of Head and Neck - diagnosis | Pathologists | Carcinoma, Transitional Cell - metabolism | Head and Neck Neoplasms - pathology | B7-H1 Antigen - metabolism | Algorithms | B7-H1 Antigen - antagonists & inhibitors | Carcinoma, Transitional Cell - pathology | Breast Neoplasms - pathology | Head and Neck Neoplasms - diagnosis | Breast Neoplasms - diagnosis | Observer Variation | Cohort Studies | Breast carcinoma | Squamous cell carcinoma | Immunotherapy | Ligands | Head and neck cancer | Lymphocytes T | Breast cancer | Urothelial carcinoma | Tumors | Apoptosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study
by Powles, Thomas and O'Donnell, Peter H and Massard, Christophe and Arkenau, Hendrik-Tobias and Friedlander, Terence W and Hoimes, Christopher J and Lee, Jae Lyun and Ong, Michael and Sridhar, Srikala S and Vogelzang, Nicholas J and Fishman, Mayer N and Zhang, Jingsong and Srinivas, Sandy and Parikh, Jigar and Antal, Joyce and Jin, Xiaoping and Gupta, Ashok K and Ben, Yong and Hahn, Noah M
JAMA oncology, ISSN 2374-2437, 08/2017, Volume 3, Issue 9, pp. e172411 - e172411
Life Sciences & Biomedicine | Oncology | Science & Technology | Abdominal Neoplasms - secondary | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Carcinoma, Transitional Cell - secondary | Antibodies, Monoclonal - therapeutic use | Male | Response Evaluation Criteria in Solid Tumors | Antineoplastic Agents - therapeutic use | Liver Neoplasms - chemistry | Abdominal Neoplasms - chemistry | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Abdominal Neoplasms - drug therapy | Liver Neoplasms - drug therapy | Survival Rate | Disease-Free Survival | Retreatment | Carcinoma, Transitional Cell - chemistry | Carcinoma, Transitional Cell - drug therapy | Aged | B7-H1 Antigen - analysis | Neoplasm Staging | Index Medicus | Online First | Online Only | Research | Original Investigation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
by Wang, Bo and Wu, Shaoxu and Zeng, Hong and Liu, Zhuowei and Dong, Wen and He, Wang and Chen, Xu and Dong, Xiaoliang and Zheng, Limin and Lin, Tianxin and Huang, Jian
The Journal of urology, ISSN 0022-5347, 2015, Volume 194, Issue 2, pp. 556 - 562
Urology | lymphocytes | tumor infiltrating | carcinoma | urinary bladder | CD8 | antigens | prognosis | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Carcinoma, Transitional Cell - mortality | Immunohistochemistry | Antigens, CD - immunology | Prognosis | Humans | Middle Aged | Male | Urinary Bladder - pathology | Antigens, CD - metabolism | Young Adult | Integrin alpha Chains - immunology | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Retrospective Studies | Urinary Bladder Neoplasms - mortality | Survival Rate - trends | Urinary Bladder - metabolism | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Proportional Hazards Models | Urinary Bladder - immunology | Integrin alpha Chains - metabolism | China - epidemiology | Disease-Free Survival | Carcinoma, Transitional Cell - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Carcinoma, Transitional Cell - immunology | Adolescent | Fluorescent Antibody Technique | Urinary Bladder Neoplasms - immunology | Aged | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Clonal evolution of chemotherapy-resistant urothelial carcinoma
by Faltas, Bishoy M and Prandi, Davide and Tagawa, Scott T and Molina, Ana M and Nanus, David M and Sternberg, Cora and Rosenberg, Jonathan and Mosquera, Juan Miguel and Robinson, Brian and Elemento, Olivier and Sboner, Andrea and Beltran, Himisha and Demichelis, Francesca and Rubin, Mark A
Nature genetics, ISSN 1061-4036, 12/2016, Volume 48, Issue 12, pp. 1490 - 1499
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Prospective Studies | Humans | Neural Cell Adhesion Molecule L1 - genetics | Carcinoma, Transitional Cell - secondary | Mutagenesis - genetics | APOBEC-1 Deaminase - genetics | Urinary Bladder Neoplasms - drug therapy | Clonal Evolution - genetics | Mutation - genetics | Clone Cells - metabolism | Exome | Drug Resistance, Neoplasm - genetics | Clone Cells - pathology | Urinary Bladder Neoplasms - genetics | Carcinoma, Transitional Cell - drug therapy | Urinary Bladder Neoplasms - pathology | Antineoplastic Agents - pharmacology | High-Throughput Nucleotide Sequencing | Carcinoma, Transitional Cell - genetics | Studies | Medical research | Chemotherapy | Lymphatic system | Editing | Phylogenetics | Mutation | Metastasis | Patients | Tumors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A molecular taxonomy for urothelial carcinoma
by Sjödahl, Gottfrid and Lauss, Martin and Lövgren, Kristina and Chebil, Gunilla and Gudjonsson, Sigurdur and Veerla, Srinivas and Patschan, Oliver and Aine, Mattias and Fernö, Mårten and Ringnér, Markus and Månsson, Wiking and Liedberg, Fredrik and Lindgren, David and Höglund, Mattias
Clinical cancer research, ISSN 1078-0432, 06/2012, Volume 18, Issue 12, pp. 3377 - 3386
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Cell Cycle - genetics | Cell Adhesion - genetics | Urinary Bladder Neoplasms - classification | Humans | Male | Mutation Rate | Gene Expression Profiling | Genetic Markers | Carcinoma, Transitional Cell - classification | Urinary Bladder Neoplasms - genetics | Carcinoma, Transitional Cell - pathology | Receptor Protein-Tyrosine Kinases - genetics | Urinary Bladder Neoplasms - pathology | Female | Biomarkers, Tumor - genetics | Keratins - genetics | Carcinoma, Transitional Cell - genetics | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
by Babjuk, Marko and Böhle, Andreas and Burger, Maximilian and Capoun, Otakar and Cohen, Daniel and Compérat, Eva M and Hernández, Virginia and Kaasinen, Eero and Palou, Joan and Rouprêt, Morgan and van Rhijn, Bas W.G and Shariat, Shahrokh F and Soukup, Viktor and Sylvester, Richard J and Zigeuner, Richard
European urology, ISSN 0302-2838, 2016, Volume 71, Issue 3, pp. 447 - 461
Urology | Cystectomy | Transurethral resection (TUR) | Prognosis | Intravesical chemotherapy | Bacillus Calmette-Guérin (BCG) | Diagnosis | Urothelial carcinoma | Bladder cancer | European Association of Urology | Guidelines | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Adjuvants, Immunologic - administration & dosage | Carcinoma in Situ - pathology | Neoplasm Invasiveness | Europe | Humans | Cystoscopy | Carcinoma, Transitional Cell - therapy | Antineoplastic Agents - administration & dosage | Carcinoma in Situ - therapy | Urinary Bladder - pathology | Societies, Medical | Carcinoma, Transitional Cell - pathology | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - pathology | Administration, Intravesical | Neoplasm Staging | Muscle, Smooth - pathology | BCG Vaccine - administration & dosage | Practice Guidelines as Topic | Medical colleges | Carcinoma | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights